Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.Read More
Seralite® – FLC ELISA
Accurate measurement of both kappa and lambda free light chains (FLCs) across a diverse range of patient cohorts.Read More
Need our help with your lateral flow assay growth strategy? https://t.co/Z4zDmKnw35 https://t.co/UjkKdqwhpU
26 May 2017
© Abingdon Health 2017